Table 5.
DNA Methyl Transferase Inhibitors: Mode of inhibition and Current Status.
DNMTi COMPOUND | NAMES | DNMT SPECIFICITY |
STATUS | REF |
---|---|---|---|---|
NUCLEOSIDE ANOLOGUES | ||||
![]() |
Azacitine (5-Aza-CR) |
DNA DNMT ADUCTs |
APPROVED | 96 |
![]() |
Decitabine (5-Aza-CdR) |
DNA/RNA DNMT ADUCTs |
APPROVED | 96 |
![]() |
Zebularine | DNA/RNA DNMT ADUCTs |
Preclinical | 102-109 |
![]() |
5-Fluoro- deoxycytidine (FdCyd/FDAC) |
DNA/RNA DNMT ADUCTs |
Phase I/II | 111-114 |
NON-NUCLEOSIDE ANOLOGUES | ||||
![]() |
Procaine | DNMT1 | Phase I | 115 |
![]() |
Procanamide | DNMT1 | Phase I | 119 |
![]() |
Hydralazine | DNMT1, DNMT3A & 3B |
Phase II/III | 116-118 |
![]() |
RG108 | DNMT1 | IC50 = 1000μM | 121 |
Red circles denote unique atoms or side groups relative to the parent compound.